Comparing two oxytocin doses to start labor in women with obesity
Compares a higher and a lower oxytocin dose to induce labor in women with obesity.
Plain-language title generated from the registry record
Registry title: Comparing High Versus Low Dose of Oxytocin, in Gravida Women With BMI 30 and Above Which Are Undergoing Induction of Labor
Key facts
- Where
- Afula, IsraelSee the site
- Phase
- Phase 4
Where in Israel
- Haemek Medical CenterAfula, IsraelNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- HaEmek Medical Center, Israel
- Trial code
- NCT06990217
- Record updated
- 25 May 2025
- Original description
The goal of this clinical trial is to compare between higher and lower dose of oxytocin to induce delivery in obese women. Researches will compare between low and high doses of oxytocin. the study group will use high dose of oxytocin (20 units in 1000 ml) versus the control group which will use low dose of oxytocin (10 units of oxytocin in 1000 ml)Read full original descriptionShow less
Comparison of Oxytocin Dosing Regimen' Low Versus High, in Gravida Women With BMI 30 and Above Undergoing Induction of Labor
The goal of this clinical trial is to compare between higher and lower dose of oxytocin to induce delivery in obese women. Researches will compare between low and high doses of oxytocin. the study group will use high dose of oxytocin (20 units in 1000 ml) versus the control group which will use low dose of oxytocin (10 units of oxytocin in 1000 ml)
Inclusion: Women at term (37-42 weeks), requiring the use of oxytocin for induction of labor or for augmentation of labor; BMI 30 and above; Viable singleton pregnancies; Cephalic presentation; No contraindication for vaginal delivery.
Exclusion: Women with previous cesarean delivery; Multiple pregnancy; Multiple fetal malformations; IUFD.